Atrás
También listada como
EKTAF
OTC
Rango del Día
$5.92
$6.02
Rango de 52 Semanas
$4.35
$6.93
Volumen
280
Promedio 50D / 200D
$6.29
/
$5.45
Cierre Anterior
$5.87
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 9.6 | 0.4 |
| P/B | 0.3 | 2.9 |
| ROE % | 2.4 | 3.8 |
| Net Margin % | 1.3 | 3.9 |
| Rev Growth 5Y % | 7.0 | 10.0 |
| D/E | 0.9 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$4.10
$3.95 – $4.40
|
18 B | 1 |
| FY2026 |
$3.64
$3.50 – $3.90
|
17 B | 1 |
Puntos Clave
Revenue grew 6.96% annually over 5 years — modest growth
Earnings declined -81.80% over the past year
ROE of 2.42% is below average
Generating 1.06B in free cash flow
P/E of 9.61 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.53%
Crecimiento
Revenue Growth (5Y)
6.96%
Revenue (1Y)-0.57%
Earnings (1Y)-81.80%
FCF Growth (3Y)62.48%
Calidad
Return on Equity
2.42%
ROIC4.08%
Net Margin1.32%
Op. Margin4.94%
Seguridad
Debt / Equity
0.86
Current Ratio1.09
Interest Coverage2.14
Valoración
P/E Ratio
9.61
P/B Ratio0.26
EV/EBITDA7.74
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.57% | Revenue Growth (3Y) | 3.34% |
| Earnings Growth (1Y) | -81.80% | Earnings Growth (3Y) | -49.87% |
| Revenue Growth (5Y) | 6.96% | Earnings Growth (5Y) | -34.07% |
| Profitability | |||
| Revenue (TTM) | 18.02B | Net Income (TTM) | 237.00M |
| ROE | 2.42% | ROA | 0.82% |
| Gross Margin | 37.44% | Operating Margin | 4.94% |
| Net Margin | 1.32% | Free Cash Flow (TTM) | 1.06B |
| ROIC | 4.08% | FCF Growth (3Y) | 62.48% |
| Safety | |||
| Debt / Equity | 0.86 | Current Ratio | 1.09 |
| Interest Coverage | 2.14 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 9.61 | P/B Ratio | 0.26 |
| P/S Ratio | 0.13 | PEG Ratio | -0.96 |
| EV/EBITDA | 7.74 | Dividend Yield | 0.05% |
| Market Cap | 2.28B | Enterprise Value | 6.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.02B | 18.12B | 16.87B | 14.55B | 13.76B |
| Net Income | 237.00M | 1.30B | 943.00M | 1.15B | 1.25B |
| EPS (Diluted) | 0.62 | 3.41 | 2.47 | 3.02 | 3.28 |
| Gross Profit | 6.75B | 6.80B | 6.35B | 5.44B | 5.61B |
| Operating Income | 890.00M | 2.04B | 1.43B | 1.64B | 1.91B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 28.98B | 31.41B | 29.61B | 26.30B | 24.84B |
| Total Liabilities | 20.13B | 20.63B | 19.88B | 17.39B | 16.65B |
| Shareholders' Equity | 8.80B | 10.78B | 9.73B | 8.91B | 8.20B |
| Total Debt | 7.57B | 7.25B | 6.67B | 5.70B | 6.24B |
| Cash & Equivalents | 2.96B | 2.77B | 3.27B | 3.07B | 4.40B |
| Current Assets | 13.42B | 13.96B | 14.38B | 12.88B | 13.25B |
| Current Liabilities | 12.35B | 14.00B | 12.71B | 11.56B | 11.94B |